Tumores Gastrintestinais

Diretriz NCCN | Câncer gástrico.

2 Mai, 2022 | 13:30h

Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology – Journal of the National Cancer Comprehensive Network

---

Diretriz de consenso | Diagnóstico e tratamento do risco de câncer nas síndromes poliposas hamartomatosas gastrintestinais.

29 Abr, 2022 | 15:07h

Diagnosis and Management of Cancer Risk in the Gastrointestinal Hamartomatous Polyposis Syndromes: Recommendations From the US Multi-Society Task Force on Colorectal Cancer

---

Análise crítica das diretrizes para o tratamento de pólipos da vesícula biliar.

27 Abr, 2022 | 16:07h

Critical Analysis of the Updated Guidelines for Management of Gallbladder Polyps – Annals of Surgical Oncology (se o acesso a este link for pago, tente este)

Conteúdo relacionado: Management and follow-up of gallbladder polyps: updated joint guidelines between the ESGAR, EAES, EFISDS and ESGE – European Radiology

---

Revisão ampla e comparativa das diretrizes globais de tratamento do câncer gástrico.

27 Abr, 2022 | 16:05h

A Comprehensive and Comparative Review of Global Gastric Cancer Treatment Guidelines – Journal of Gastric Cancer

---

Estudo randomizado | Pembrolizumabe vs. quimioterapia para câncer colorretal metastático com alta instabilidade microssatélite ou deficiência no reparo de incompatibilidade (mismatch repair – MMR).

27 Abr, 2022 | 15:03h

Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study – The Lancet Oncology (link para o resumo – $ para o texto completo)

Comentário: Overall Survival in KEYNOTE-177: Pembrolizumab vs Chemotherapy in Microsatellite Instability–High or Mismatch Repair–Deficient Metastatic Colorectal Cancer – The ASCO Post

---

M-A | Eficácia clínica dos tratamentos adjuvantes para pacientes com câncer de vias biliares ressecado.

25 Abr, 2022 | 12:37h

Clinical efficacy of adjuvant treatments for patients with resected biliary tract cancer: a systematic review and network meta-analysis – BMJ Open

---

Inteligência artificial (AI) reduz a taxa de erro no rastreamento de pólipos pré-cancerosos no câncer colorretal.

21 Abr, 2022 | 11:19h

Comunicado de imprensa: AI reduces miss rate of precancerous polyps in colorectal cancer screening – Mayo Clinic

Estudo original: Impact of Artificial Intelligence on Miss Rate of Colorectal Neoplasia – Gastroenterology (link para o resumo – $ para o texto completo)

---

Revisão | Terapia de primeira linha para carcinoma hepatocelular avançado.

21 Abr, 2022 | 11:12h

Frontline therapy for advanced hepatocellular carcinoma: an update – Therapeutic Advances in Gastroenterology

---

M-A de estudos randomizados controlados | Anastomose intratorácica vs. cervical na esofagectomia para câncer esofágico.

14 Abr, 2022 | 16:44h

Intrathoracic versus cervical anastomosis in esophagectomy for esophageal cancer: A meta-analysis of randomized controlled trials – Surgery

---

Análise sistemática para o Global Burden of Disease Study 2019 | Impacto global, regional e nacional do câncer colorretal e seus fatores de risco, 1990-2019.

11 Abr, 2022 | 13:03h

Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 – The Lancet Gastroenterology & Hepatology

Comentário convidado: Global epidemiology and prevention of colorectal cancer – The Lancet Gastroenterology & Hepatology (necessário cadastro gratuito)

---